The school will work with the FDA's toxicology center to study gene expression and other effects of botanical estrogens taken as supplements and in consumer products.
In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.
